logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Medi Assist: A Quarter of Robust Growth, Margin Expansion, and Strategic Tech-Led Transformation

MEDIASSIST

Medi Assist Healthcare Services Ltd

MEDIASSIST

Ask AI

Ask AI

Medi Assist Healthcare Services Limited, a prominent technology-driven health benefits administrator in India, has reported a strong performance for Q3 and 9-month FY26, ending December 31, 2025. The company demonstrated significant financial and operational advancements, marked by substantial revenue growth, impressive margin expansion, and a crucial shift to a debt-free balance sheet. This period underscores Medi Assist’s commitment to redefining health benefits administration through AI-powered, technology-led solutions and strategic integrations.

For the 9-month period of FY26, Medi Assist achieved a consolidated total income of INR 680.0 crore, reflecting a robust 23.5% year-on-year growth. Revenue from contracts also grew by 24.0% year-on-year, reaching INR 662.8 crore. The company’s EBITDA stood at INR 128.9 crore, marking a 13.8% year-on-year increase. Notably, the EBITDA margin for Q3 FY26 (ex-Paramount) improved to 21.8%, a 50 basis points quarter-on-quarter expansion, while the consolidated EBITDA margin was 18.6%, showing a 154 basis points quarter-on-quarter improvement. The adjusted PAT for 9M FY26 reached INR 46.3 crore, excluding one-time exceptional items. A significant highlight was the company’s transition to a debt-free status as of January 2026, with debt reduced from INR 243.4 crore in September 2025 to INR 39.4 crore in December 2025.

Operational Excellence and Market Leadership

Medi Assist continues to solidify its market leadership, with total premiums under management (Group + Retail) growing by 21.9% year-on-year to INR 19,298.1 crore. This expansion contributed to an overall market share increase to 21.1%, up by 133 basis points year-on-year, and a group market share of 32.2%, an increase of 307 basis points year-on-year. The company served over 39 crore lives annually across all business lines and processed 72.9 lakh claims in the 9-month period, representing a 22.4% year-on-year growth in claims volume. This high throughput is a testament to its scalable operations and technology infrastructure.

The company’s focus on technology-led solutions is evident in its AI-powered platforms. MAven Guard, designed for fraud, waste, and abuse detection, identified approximately INR 400 crore in potential fraud, marking a 65.9% year-on-year increase. This system- and AI-driven identification accounted for 81.5% of the detected fraud, significantly reducing unnecessary investigations by 630 basis points and improving policyholder experience. Raksha Prime, another AI-enabled offering, revolutionizes cashless discharges, enabling ~35,000 patients per month to leave hospitals without waiting for bills across ~6,000 hospitals, achieving an average experience rating of 4.75/5.

Strategic Integrations and Future Outlook

The integration of Paramount TPA is progressing as planned, with significant milestones achieved in technology consolidation. Corporate policies are being successfully migrated to the Medi Assist stack, and key AI capabilities are being enabled for Paramount clients. The Board approved a slump transfer of Paramount TPA business to Medi Assist TPA effective February 1, 2026, which is expected to accelerate integration and operational synergies, allowing the company to manage its entire retail business as a single entity.

Medi Assist is also expanding its international footprint. The international benefits administration segment contributed 4.5% to consolidated revenues, growing by 16.3% year-on-year. The company signed three new insurer partnerships for travelers to and from India, gaining access to 19% of the overseas medical market in India. Customer migration to the new HealthX platform is 98% complete, and new partnerships in North America are improving unit economics. The marine yacht business also saw strong growth with 27 new customers.

Management is optimistic about the future, aiming to restore core EBITDA margins within the next two to three quarters through disciplined execution of the Paramount integration. The company plans to further invest in tech deployments and acquire new customers for its tech business, both domestically and internationally, expecting tech revenues to be margin accretive at a faster rate. The debt-free status provides financial flexibility to accelerate these initiatives.

Key Financial Highlights

MetricQ3 FY26 (Consolidated)9M FY26 (Consolidated)
Total Income (INR Cr)247.2680.0
Revenue from Contracts (INR Cr)239.7662.8
EBITDA (INR Cr)44.6126.3
EBITDA Margin (%)18.619.1
Adjusted PAT (INR Cr)N/A46.3

*Note: Figures marked with '#' represent consolidated numbers for Medi Assist and Paramount Health Services.

Driving Sustainable Growth and Innovation

Medi Assist’s Q3 and 9M FY26 performance reflects a strategic clarity focused on leveraging technology, expanding market reach, and enhancing operational efficiency. The successful integration of Paramount, coupled with the robust performance of its AI-led platforms like MAven Guard and Raksha Prime, positions the company for sustained profitable growth. By continuously innovating and focusing on measurable outcomes for all stakeholders, Medi Assist is not only strengthening its market position but also creating a transformative impact across the Indian and international healthcare ecosystems. The company’s journey towards a debt-free balance sheet further reinforces its financial resilience and capacity for future strategic investments.

Frequently Asked Questions

For Q3 FY26, Medi Assist reported a consolidated total income of INR 247.2 Cr and EBITDA of INR 44.6 Cr. For 9M FY26, consolidated total income was INR 680.0 Cr (23.5% YoY growth) and EBITDA was INR 126.3 Cr (11.5% YoY growth). The company also achieved a debt-free balance sheet as of January 2026.
The Paramount TPA integration is progressing as expected, with corporate policies migrating to the Medi Assist stack and AI capabilities enabled for Paramount clients. A slump transfer of Paramount TPA business to Medi Assist TPA was effective February 1, 2026, accelerating integration and operational synergies. Paramount's standalone margins improved by 557 bps quarter-on-quarter.
Medi Assist's key AI platforms include MAven Guard, which identified ~INR 400 Cr in potential fraud (+65.9% YoY), and Raksha Prime, which enables ~35,000 patients/month bill-free discharge across ~6,000 hospitals with a 4.75/5 average experience rating. MAgnum is a new provider-facing digital platform enabling self-service for these capabilities.
Medi Assist is expanding internationally by signing new insurer relationships for travelers to and from India, gaining access to 19% of the overseas medical market. They have also achieved 98% customer migration to the HealthX platform and established new partnerships in North America to improve unit economics. The Marine Yacht Business added 27 new customers.
Challenges included a cybersecurity incident at Paramount resulting in an INR 3.8 Cr PAT impact, an INR 3.3 Cr impact from new labor code assessments, and a provision of INR 7.1 Cr for disputed claims. The retail market share also saw a marginal dip due to PSU portfolio reallocation.
Management expects to restore core EBITDA margins within the next 2-3 quarters through disciplined Paramount integration. They plan to continue investing in tech deployments and acquiring new tech customers in India and overseas, anticipating tech revenues to be margin accretive. The debt-free status is expected to eliminate future finance charges.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker